LncRNAs Disease Experimental methods Regulated Pubmed ID Year
LINC01133esophageal squamous cell carcinomaqPCRL300079822018
LINC01133breast cancerqPCR, Western blot, RIPL315574012019
LINC01133nasopharyngeal cancerqRT-PCR , Western blot , RIP , RNAi , in vitro knockdown etc.L311060032019
LINC01133gastric cancerqPCR, Luciferase assayL301349152018
LINC01133oral squamous cell carcinomaqPCR, Western blot, OtherL303325102018
LINC01133pancreatic cancerqPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc.H305806762019
LINC01133hepatocellular carcinomaqPCR, Western blot, in vitro knockdown, etc.H305483062018
LINC01133cervical cancerqPCR, Western blot, Luciferase reporter assay, RIPH313909322019
LINC01133triple negative breast cancerqPCR, Western blotH312830682019
LINC01133pancreatic ductal adenocarcinomaqPCR etc.H294581452018
LINC01133osteosarcomaqPCRH283901152017
LINC01133colorectal cancerqPCRL285376752017
LINC01133colorectal cancerqPCR, Western blot, RIP etc.L274436062016
LINC01133non small cell lung cancerqPCR, RNAi, Western blot, RIP, Flow cytometry assay, Cell proliferation assay etc.H268400832016
LINC01133lung squamous cell carcinomamicroarray, qPCR, RNAi etc.H259081742015
LINC01133esophageal squamous cell carcinomaqRT-PCR ect.L300079822018
LINC01133Ovarian cancerqRT-PCRL330367572020